These effects associated with a reduction in CXCR4+ target cancer cell fraction in tumor tissue, being both the antimetastatic effect and the reduction in CXCR4+ CCF highly significant in LV, LG, and PTN Mets, whereas they were non‐significant in primary tumor or LN Mets. Here, CXCR4 is linked to cancer.